GAS2 and chronic myelogenous leukemia, BCR-ABL1 positive: In the present study, we compared the expression of GAS2 in chronic phase CML patients to that in healthy donors; we also addressed whether and how the deregulated GAS2 contributed to the growth of CML cells.